EUVIMEDEUVIMED entdecken
Crossref

Challenges and optimization strategies for copper-mediated radiofluorination of pyridine-based potential PET radiotracer targeting IDH1R132H in brain tumours

M Diwaker, R P Moldovan, S Dukic-Stefanovic, G D Bowden, A Maurer, W Deuther-Conrad, B Wenzel

Nuklearmedizin - NuclearMedicine · 01.04.2026 · 65 (02) · 111

DOI: 10.1055/s-0046-1818202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.04.2026. Verfasst von M Diwaker und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ziel/Aim: Copper-mediated radiofluorination (CMRF) enables late-stage radiofluorination of structurally diverse PET probes, yet its application to electron-deficient heteroaromatics, particularly at the meta-position of pyridines, remains inconsistent. [ 1 ] [ 2 ],This study aims to optimize copper-mediated radiofluorination (CMRF) conditions for a 3-pyridylbenzodiazepine derivative exhibiting low-nanomolar potency towards IDH1R132H, a key prognostic biomarker in astrocytoma and oligodendroglioma. [ 3 ] Methodik/Methods: Optimization was performed by: (1) screening precursors with different leaving groups including 3-pyridylboronic esters (BPin, EPin), 3-pyridylstannane, and their Boc-protected analogues; (2) evaluating effect of reaction temperature and solvent systems; (3) comparing copper sources [Cu(OTf)₂(py)₄], [Cu(4-PhPy)₄(ClO₄)₂], [Cu(Impy)₄(OTf)₂], and Cu(OTf)₂; (4) testing different preconditioning agents for QMA cartridge; and (5) assessing different phase transfer agents for elution. Ergebnisse/Results: [Cu(OTf)₂(py)₄] produced a RCC of 5% with the BPin precursor in DMI, while EPin and stannane analogues gave slightly lower yields. Boc protection of Bpin improved RCC to 10%. Among copper sources, [Cu(4-PhPy)₄(ClO₄)₂] achieved the highest RCC (17%), increasing to 20% when the 4-phenylpyridine ligand was added separately to Cu(OTf)₂. Initial attempts showed that preconditioning of the QMA cartridge with KOTf further slightly enhanced RCC to 24%, whereas elevated temperature (100 to 140 ᵒC) showed no improvement. Schlussfolgerungen/Conclusion: Protection of the secondary amine resulted in improved RCC, while higher copper loadings and temperature increases were ineffective. These results illustrate the complex nature of CMRF and emphasize that careful optimization of multiple interdependent factors is required. Further experiments are in progress, including the systematic screening of additional ligands and ligand–copper complexes to enhance RCC and understand key parameters governing successful radiolabeling. Publication History Article published online: 02 April 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Diwaker, M., Moldovan, R. P., Dukic-Stefanovic, S., Bowden, G. D., Maurer, A., Deuther-Conrad, W., & Wenzel, B. (2026). Challenges and optimization strategies for copper-mediated radiofluorination of pyridine-based potential PET radiotracer targeting IDH1R132H in brain tumours. Nuklearmedizin - NuclearMedicine, 65(02), 111. https://doi.org/10.1055/s-0046-1818202

Vancouver

Diwaker M, Moldovan RP, Dukic-Stefanovic S, Bowden GD, Maurer A, Deuther-Conrad W, et al. Challenges and optimization strategies for copper-mediated radiofluorination of pyridine-based potential PET radiotracer targeting IDH1R132H in brain tumours. Nuklearmedizin - NuclearMedicine. 2026;65(02):111. doi:10.1055/s-0046-1818202

BibTeX
@article{Diwaker2026,
  author = {Diwaker, M and Moldovan, R P and Dukic-Stefanovic, S and Bowden, G D and Maurer, A and Deuther-Conrad, W and Wenzel, B},
  title = {Challenges and optimization strategies for copper-mediated radiofluorination of pyridine-based potential PET radiotracer targeting IDH1R132H in brain tumours},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2026},
  volume = {65},
  number = {02},
  pages = {111},
  doi = {10.1055/s-0046-1818202}
}
Kostenlos starten →